ATE277003T1 - INTERMEDIATE PRODUCT FOR PRODUCING CONDENSED BENZAZEPINE DERIVATIVES - Google Patents

INTERMEDIATE PRODUCT FOR PRODUCING CONDENSED BENZAZEPINE DERIVATIVES

Info

Publication number
ATE277003T1
ATE277003T1 AT00204704T AT00204704T ATE277003T1 AT E277003 T1 ATE277003 T1 AT E277003T1 AT 00204704 T AT00204704 T AT 00204704T AT 00204704 T AT00204704 T AT 00204704T AT E277003 T1 ATE277003 T1 AT E277003T1
Authority
AT
Austria
Prior art keywords
intermediate product
benzazepine derivatives
producing condensed
condensed benzazepine
derivatives
Prior art date
Application number
AT00204704T
Other languages
German (de)
Inventor
Akihiro Tanaka
Hiroyuki Koshio
Nobuaki Taniguchi
Akira Matsuhisa
Ken-Ichiro Sakamoto
Atsuki Yamazaki
Takeyuki Yatsu
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE277003T1 publication Critical patent/ATE277003T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

(Biphenyl-2-ylcarboxamide)benzoic acid is useful on an intermediate for the synthesis of condensed benzazepine derivatives which are arginine vasopressin antagonists.
AT00204704T 1993-07-21 1994-07-19 INTERMEDIATE PRODUCT FOR PRODUCING CONDENSED BENZAZEPINE DERIVATIVES ATE277003T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18043593 1993-07-21

Publications (1)

Publication Number Publication Date
ATE277003T1 true ATE277003T1 (en) 2004-10-15

Family

ID=16083198

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00204704T ATE277003T1 (en) 1993-07-21 1994-07-19 INTERMEDIATE PRODUCT FOR PRODUCING CONDENSED BENZAZEPINE DERIVATIVES
AT94921117T ATE239726T1 (en) 1993-07-21 1994-07-19 FUSED BENZAZEPINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94921117T ATE239726T1 (en) 1993-07-21 1994-07-19 FUSED BENZAZEPINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME

Country Status (18)

Country Link
US (2) US5723606A (en)
EP (2) EP1097920B1 (en)
KR (1) KR100304331B1 (en)
CN (1) CN1040210C (en)
AT (2) ATE277003T1 (en)
AU (2) AU683483B2 (en)
CA (1) CA2167673C (en)
DE (2) DE69434032T2 (en)
ES (2) ES2198418T3 (en)
FI (1) FI113178B (en)
HU (1) HUT74582A (en)
NO (1) NO306303B1 (en)
NZ (1) NZ268671A (en)
PL (1) PL177738B1 (en)
RU (1) RU2129123C1 (en)
TW (1) TW279163B (en)
UA (1) UA64690C2 (en)
WO (1) WO1995003305A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760031A (en) * 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5693635A (en) * 1993-07-29 1997-12-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AR002459A1 (en) * 1995-01-17 1998-03-25 American Cyanamid Co TRASCINIC BENZACEPINE VASOPRESIN ANTAGONISTS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, A METHOD FOR TREATING DISEASES AND A PROCEDURE FOR THEIR PREPARATION.
WO1999038533A1 (en) * 1998-01-28 1999-08-05 Senju Pharmaceutical Co., Ltd. Preventives or remedies for vision disorders
AR018818A1 (en) * 1998-04-03 2001-12-12 Yamano Masaki A PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF AN EDEMA.
WO1999065525A1 (en) * 1998-06-19 1999-12-23 Wakamoto Pharmaceutical Co., Ltd. Ocular tension lowering agents and phosphoric ester derivatives
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
US6765004B1 (en) 1999-06-17 2004-07-20 Ortho-Mcneil Pharmaceutical, Inc. Indoloazepines as vasopressin receptor antagonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
DE60031171T2 (en) * 2000-01-26 2007-08-23 Astellas Pharma Inc. ACE INHIBITOR VASOPRESSINE ANTAGONIST COMBINATIONS
US6645959B1 (en) 2000-01-26 2003-11-11 Warner-Lambert Company Method for treating postoperative ileus
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) * 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
AU779929B2 (en) * 2000-10-04 2005-02-17 Warner-Lambert Company Treatment of pulmonary hypertension
ES2288899T3 (en) 2000-10-04 2008-02-01 Astellas Pharma Inc. USE OF A VASOPRESIN ANTAGONIST AS CONIVAPT IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PULMONARY HYPERTENSION.
CA2425892A1 (en) * 2000-11-28 2003-04-11 Hiroyuki Koshio 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivative or salt thereof
EP2016065B1 (en) * 2005-12-28 2012-09-19 Vertex Pharmaceuticals Incorporated 1-(benzo[d][1,3]dioxol-5-yl)-n-(phenyl)cyclopropane-carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US20080221084A1 (en) * 2006-10-30 2008-09-11 Otsuka Pharmaceutical Co., Ltd. Method for reducing infarction using vasopressin antagonist compounds, and compositions and combinations therefor
US20090069295A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched conivaptan
AU2009204147A1 (en) * 2008-01-07 2009-07-16 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
WO2009102761A1 (en) * 2008-02-12 2009-08-20 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
EP2315751A1 (en) * 2008-06-26 2011-05-04 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2011052519A1 (en) 2009-10-26 2011-05-05 大塚製薬株式会社 Benzazepine compound
US20150238502A1 (en) 2012-10-18 2015-08-27 University Of South Florida Compositions and Methods for Treating Stroke
CN103497195B (en) * 2013-10-21 2016-01-27 北京科莱博医药开发有限责任公司 Conivaptan-hydrochlonovel novel crystal form and preparation method thereof
CN105310978A (en) * 2014-08-04 2016-02-10 李峰 Drug combination containing conivaptan hydrochloride as active ingredient and preparation of drug combination
CN105884778A (en) * 2014-09-24 2016-08-24 李峰 Compound and preparation method thereof
CN105153168A (en) * 2015-09-29 2015-12-16 上海天慈国际药业有限公司 Preparation method of N-[4-(2-methyl-4,5-dihydro-3H-imidazo [4,5-d] [1] benzazepin-6-formyl) phenyl]-2-phenylbenzamide hydrochloride
CN106317060B (en) * 2016-08-22 2019-02-15 山东罗欣药业集团恒欣药业有限公司 A kind of preparation method of hydrochloric acid conivaptan
WO2019036024A1 (en) 2017-08-17 2019-02-21 Bristol-Myers Squibb Company 2-(1,1 '-biphenyl)-1 h-benzo[d]imidazole derivatives and related compounds as apelin and apj agonists for treating cardiovascular diseases
HU231206B1 (en) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepines
TW201938171A (en) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 Tricyclic compounds as vasopressin V1a receptor antagonists
WO2022111581A1 (en) * 2020-11-26 2022-06-02 上海济煜医药科技有限公司 Novel benzazepine spiro derivative

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG28353G (en) * 1988-06-15 1995-09-18 Givaudan Roure Int Benzamidines useful as ultraviolet light absorbers
US5011628A (en) * 1988-06-15 1991-04-30 Givaudan Corporation N,N'-diarylbenzamidines useful as ultraviolet light absorbers
US5225402A (en) * 1989-02-10 1993-07-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2905909B2 (en) * 1991-04-19 1999-06-14 大塚製薬株式会社 Vasopressin antagonist
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
DE122009000062I2 (en) * 1989-10-20 2011-01-13 Otsuka Pharma Co Ltd BENZOHETEROCYCLIC COMPOUNDS
JPH03255077A (en) * 1990-03-01 1991-11-13 Taiji Nakayama Pyrimidine derivative and platelet coagulation inhibitor with the same as active ingredient
CA2066104C (en) * 1991-04-19 2003-05-27 Hidenori Ogawa Benzazepine derivatives as vasopressin antagonists
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
JP3255077B2 (en) * 1997-04-23 2002-02-12 日本電気株式会社 Phone

Also Published As

Publication number Publication date
AU3990697A (en) 1997-12-18
AU683483B2 (en) 1997-11-13
CA2167673C (en) 2004-09-21
HU9600102D0 (en) 1996-03-28
ES2228405T3 (en) 2005-04-16
DE69432632T2 (en) 2004-02-19
FI960260A (en) 1996-01-19
TW279163B (en) 1996-06-21
CA2167673A1 (en) 1995-02-02
ATE239726T1 (en) 2003-05-15
NZ268671A (en) 1997-09-22
NO960231D0 (en) 1996-01-19
EP0709386A1 (en) 1996-05-01
CN1127508A (en) 1996-07-24
ES2198418T3 (en) 2004-02-01
RU2129123C1 (en) 1999-04-20
NO306303B1 (en) 1999-10-18
DE69434032T2 (en) 2005-09-22
WO1995003305A1 (en) 1995-02-02
US5723606A (en) 1998-03-03
UA64690C2 (en) 2004-03-15
EP1097920A1 (en) 2001-05-09
PL177738B1 (en) 2000-01-31
NO960231L (en) 1996-03-21
HUT74582A (en) 1997-01-28
DE69434032D1 (en) 2004-10-28
DE69432632D1 (en) 2003-06-12
PL312654A1 (en) 1996-04-29
FI113178B (en) 2004-03-15
EP0709386B1 (en) 2003-05-07
FI960260A0 (en) 1996-01-19
KR100304331B1 (en) 2001-11-22
EP1097920B1 (en) 2004-09-22
CN1040210C (en) 1998-10-14
EP0709386A4 (en) 1997-06-25
US5856564A (en) 1999-01-05
KR960703917A (en) 1996-08-31
AU7195794A (en) 1995-02-20

Similar Documents

Publication Publication Date Title
ATE277003T1 (en) INTERMEDIATE PRODUCT FOR PRODUCING CONDENSED BENZAZEPINE DERIVATIVES
ATE415394T1 (en) INTERMEDIATE PRODUCTS FOR PRODUCING RETROVIRAL PROTEASE INHIBITORS
DE4397599T1 (en) Process for the preparation of high-purity isomers of benzene dicarboxylic acid
DE69201934D1 (en) Process for the production of sunscreens.
DE69705292D1 (en) Iridium-catalyzed carbonylation process for the production of acetic acid
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
DE69903865D1 (en) Anhydrous carbonylation process for the production of acetic acid
DE69202307T3 (en) Cryogenic rectification process for the production of purified argon.
DE69804421D1 (en) Process for the production of Rhine and its diacyl derivatives
ATE178885T1 (en) PRODUCTION OF AMIDO ACIDS FROM CARBOXIC ACIDS AND LACTAMS
DE69424899D1 (en) Process for the production of acetic acid
ES2169053T3 (en) INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF CEPHALOSPORINS.
DE69804853D1 (en) METHOD FOR PRODUCING MEQUITAZINE AND INTERMEDIATE PRODUCT OF THE SYNTHESIS
ES2134879T3 (en) METALOZENES CONTAINING SUBSTITUTED FLUORENYL COMPOUNDS IN POSITION 9 AND USE OF METALLOCENS.
DE69206070T2 (en) Process for the production of acetic acid.
ATE119394T1 (en) USE OF MYRICETIN-3-0-BETA-D-GLUCURONIDE AS A MEDICINAL PRODUCT.
DE69109953T2 (en) Alfa-fluorocarboxylic acid derivatives as intermediates for the production of fungicides.
ATE66453T1 (en) PRODUCTION OF INTERMEDIATE COMPOUNDS FOR LEUKOTRIAN ANTAGONISTS.
CA2453123A1 (en) Intermediate for condensed benzazepine derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties